Drrx stock forecast.

Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.62What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Mar-09-21 09:00AM. DURECT Corporation Announces Publication of DUR-928's Mechanism of Action. (PR Newswire) DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic …

Astrotech's stock was trading at $9.99 at the beginning of 2023. Since then, ASTC shares have decreased by 20.9% and is now trading at $7.90. View the best growth stocks for 2023 here.marketbeat.com - June 2 at 4:40 AM. Tocqueville Asset Management L.P. Has $316,000 Position in DURECT Co. (NASDAQ:DRRX) marketbeat.com - May 19 at 7:46 AM. Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI) markets.businessinsider.com - May 18 at 8:46 AM.See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.View more. Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 30, 2023 · See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 6, 2023 · The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...

Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?May 17, 2023 · Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ... On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialBroadly, the S&P’s financial sector is down 2% year-to-date, making it the worst-performing sector, followed by energy (down 8%), utilities (8%) and healthcare (3%). Pharmaceutical giant Pfizer ...May 11, 2023 · Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...

Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Upside potential of 134% is at play.Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the ...Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.Real time Durect (DRRX) stock price quote, stock graph, news & analysis. The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...

Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update. Durect Earnings Preview. Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00. Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialDURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ... DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ...May 22, 2023 · DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.

Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.

The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)7 Jun 2023 ... Bond & Stock Ratings · Conference Call Announcements · Contracts · Cryptocurrency · Dividends · Earnings · Earnings Forecasts & Projections ...DRRX Overview Stock Screener Earnings Calendar Sectors Nasdaq | DRRX U.S.: Nasdaq Durect Corp. Watch list NEW Set a price target alert Open Last Updated: Nov 24, 2023 1:00 p.m. EST Real...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median... Forecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year.U.S. stock index futures edged up on Wednesday as investors awaited Federal Reserve Chair Jerome Powell's speech at a conference to gauge his view on interest rates and the state of the economy. At 9:07 ET, Dow e-minis (1YMc1) were up 0.13% at 34,260. S&P 500 e-minis ES1! were up 0.10% at 4,400.5, while Nasdaq 100 e …Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ... DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%.Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.Nov 14, 2023 · Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.

Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 28, 2023 · DRRX's stock price has decreased by -84.09% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase of 5,499.88%. Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...Instagram:https://instagram. will the shingles vaccine help with herpes outbreaksfutures trading robinhoodsw airlines stockthe new economy fund Durect Stock Prediction. AVB. 40 fidelity share price1 bar of gold worth Nov 16, 2023 · Predictions of DRRX stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks. Get the latest Checkpoint Therapeutics Inc (CKPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. voo return It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...The Takeda Pharmaceutical 52-week low stock price is 13.19, which is 6.8% below the current share price. ... DURECT (DRRX), United States, $0.018B, 0.00. Jaguar ...